bilaterals.org logo
bilaterals.org logo

medicines

Intellectual property and COVID-19 medicines: why a WTO waiver may not be enough
25-Feb-2021 The Conversation
The COVID-19 pandemic, and the race to make vaccines and other useful technologies more accessible to people around the world, has once again highlighted the tension between intellectual property rights and the promotion of public health.
UK and EU pharma call for medicines to be prioritised in Brexit trade talks
29-Sep-2020 European Pharmaceutical Review
They have both emphasised the need for trade talks to mitigate medicine supply chain disruptions following Brexit.
A new trend in trade agreements: Ensuring access to cancer drugs
17-Sep-2020 South Centre
People around the world need to be aware of precedents in recent trade agreements and ensure that they also work for access to medicines for their own citizens.
Vietnam courts EU investment in medical and drug supply chains
14-Aug-2020 Nikkei Asian Review
Vietnam seeks to build on its new free trade agreement with the European Union to expand foreign investment in medical equipment and pharmaceuticals, with the government position the country as an alternative production base to China.
India, US trade deal: New Delhi seeks preferential treatment on drugs, other goods
20-Jul-2020 Livemint
India is seeking concessions for generic drugs it exports to the United States in return for opening its dairy markets and slashing tariffs on farm goods as the two sides seek to shore up a new trade deal.
Union calls for equal recognition for healthcare workers
12-May-2020 Bangkok Post
The union and its allies also asked the government not to join the Trans-Pacific Partnership, as they view that the restriction of rights to access medicine under the deal would put the country’s public health system in danger.
If the government doesn’t halt trade talks with Trump, it’s learned nothing from coronavirus
6-May-2020 The Independent
The US trade model is not only unpopular with the British public, but it will also make us more vulnerable to future pandemics.
Covid-19: Why India doesn’t need to worry about investor-State dispute settlement claims
2-Apr-2020 Hindustan Times
In order to halt the spread of the coronavirus pandemic (Covid-19) and to boost the public health care system and preparedness, India has taken several regulatory steps.
The Comprehensive and Progressive Agreement for the Trans-Pacific Partnership: Data exclusivity and access to biologics
1-Apr-2020 South Centre
The agreement does not promise that the suspended provision on test data rule concerning biological medicines will remain suspended.
Intellectual property rights: Potential implications of the DCFTA for access to medicine
25-Mar-2020 Observatoire Tunisien de l’Economie
If the intellectual property provisions of the DCFTA are applied, this will have an impact on both the cost of patented medicines and undermine access to affordable medicines.
Can a US-India trade deal permanently alter the way Indians access medicines?
25-Feb-2020 The Wire
US-India IP engagements since 2006 have served the interests of the US through systematic undermining of the legislative safeguards in the Indian Patents Act.
Trump will insist NHS pays more for drugs in trade deal, says ambassador
31-Jan-2020 The Guardian
Donald Trump will put the interests of corporate America first and demand that the NHS pays higher prices for US drugs in a free-trade deal with the UK, the outgoing British ambassador to Washington said.
Phase 1 US China trade deal: patent provisions
30-Jan-2020 Mondaq
China agreed to extend patent terms for novel drugs "to compensate for unreasonable delays that occur in granting the patent or during pharmaceutical product marketing approvals."
India, Indonesia negotiating economic cooperation agreement
27-Jan-2020 Sunday Guardian Live
India and Indonesia are set to launch negotiations for a Comprehensive Economic Cooperation Agreement (CECA) to cover economic cooperation while trading in goods, services, and investments.
Blueprint for a human rights impact assessment of the planned comprehensive free trade agreement between EFTA and Mercosur
24-Jan-2020 Alliance Sud
This study assesses the impact of the EFTA-Mercosur free trade agreement on access to medicines, indigenous rights and women rights.
Biologic exclusivity provision stripped from revised USMCA deal
10-Dec-2019 Modern Health Care
A provision of the United States-Mexico-Canada Agreement on trade that would have guaranteed 10 years of market exclusivity for biologic drugs was removed.
Mexico sees progress in talks to revise USMCA, says drug protections to ease
5-Dec-2019 Reuters
Mexico’s government said progress was being made toward revising a new North American trade pact that will sharply reduce protections for biologic drugs.
Trump administration considers loosening drug protections in USMCA
3-Dec-2019 Fox Business
Generic versions of biologic drugs could come to market faster.
How to protect the NHS in a post-Brexit trade deal with the US
3-Dec-2019 The Conversation
There are two solutions to this impending problem, which most political parties could agree to if they are truly committed to protecting the NHS.
New AFTINET fact sheet: The impact of trade and investment rules on public health
30-Oct-2019 AFTINET
Trading away our health: How trade and investment rules put corporate rights ahead of public health.